Skip to main content

REVIEW article

Front. Bioeng. Biotechnol.
Sec. Synthetic Biology
Volume 12 - 2024 | doi: 10.3389/fbioe.2024.1511149
This article is part of the Research Topic Synthetic Biology and Microbiota Therapeutics View all articles

Advancing Microbiota Therapeutics: The Role of Synthetic Biology in Engineering Microbial Communities for Precision Medicine

Provisionally accepted
Asiya Nazir Asiya Nazir *Fathima Hasnain Nadeem Hussain Fathima Hasnain Nadeem Hussain Afsheen Raza Afsheen Raza
  • Abu Dhabi University, Abu Dhabi, United Arab Emirates

The final, formatted version of the article will be published soon.

    Over recent years, studies on microbiota research and synthetic biology have explored novel approaches microbial manipulation for therapeutic purposes. However, fragmented information is available on this aspect with key insights scattered across various disciplines such as molecular biology, genetics, bioengineering, and medicine. This review aims to the transformative potential of synthetic biology in advancing microbiome research and therapies, with significant implications for healthcare, agriculture, and environmental sustainability. By merging computer science, engineering, and biology, synthetic biology allows for precise design and modification of biological systems via cutting edge technologies like CRISPR/Cas9 gene editing, metabolic engineering, and synthetic oligonucleotide synthesis, thus paving the way for targeted treatments such as personalized probiotics and engineered microorganisms.The review will also highlight the vital role of gut microbiota in disorders caused by its dysbiosis and suggesting microbiota-based therapies and innovations such as biosensors for real-time gut health monitoring, non-invasive diagnostic tools, and automated bio foundries for better outcomes. Moreover, challenges including genetic stability, environmental safety, and robust regulatory frameworks will be discussed to understand the importance of ongoing research to ensure safe and effective microbiome interventions

    Keywords: Synthetic Biology, Gut Microbiota Therapeutics, CRISPR/Cas9 gene editing, Metabolic Engineering, personalized medicine

    Received: 14 Oct 2024; Accepted: 18 Nov 2024.

    Copyright: © 2024 Nazir, Nadeem Hussain and Raza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Asiya Nazir, Abu Dhabi University, Abu Dhabi, United Arab Emirates

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.